Tools

There is no scientific proof that people suffering from depression can benefit from taking reboxetine. However, clinical trials do provide… »   

A Philadelphia jury on Monday ordered Pfizer Inc to pay $28 million in punitive damages to a breast cancer survivor… »   

Older adults who take several types of psychotropic medications—such as antidepressants or sedatives—appear more likely to experience falls, according to… »   

Clinical trial data indicated an association between the anti-inflammatory medication rofecoxib and cardiovascular risk as early as December 2000, before… »   

Vioxx Trial Data Shows Early Cardiovascular Risk, Provides Lessons for Post-Market Pharmaceutical Safety

Evidence of cardiovascular risks associated… »   

The U.S. Food and Drug Administration has approved Bristol-Myers Squibb Co’s and Otsuka Pharmaceutical Co’s anti-psychotic drug Abilify to treat… »   

The Infectious Diseases Society of America (IDSA) has asked for a commitment from the Obama administration and the European Union… »   

Sitagliptin (known as Januvia) has been approved by the European Commission as an add-on to insulin (with or without metformin)… »   

AstraZeneca announced it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for ticagrelor,… »   

The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has adopted… »